Estados Unidos · Revistas de economía · Fast Company

Ozempic is changing how Americans spend money, and the numbers are startling

Publicado por Fast Company · Estados Unidos hace 2 h

Millions of Americans are spending potentially hundreds of dollars each month on GLP-1 medications, but that comes at a cost: Their weight-loss journey is shaking up how they…

Leer el artículo completo en Fast Company Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.fastcompany.com)

Ozempic is changing how Americans spend money, and the numbers are startling

También te puede interesar

Consumer Reports' 13 favorite gifts for cooks and travelers under $75

Gen Z Wants Something From Their Bosses That Most Managers Struggle to Give

Elon Musk promised an AI epic to rival Christopher Nolan. Viewers got a seven-minute glitch

What Multiplier's talent trends reveal about the future of work

The Best and Worst Presidents for Inflation

General Motors to move stock listing from NYSE to Nasdaq in technology-focused shift

Ozempic is changing how Americans spend money, and the numbers are startling

Compartir

También te puede interesar

Consumer Reports' 13 favorite gifts for cooks and travelers under $75

Gen Z Wants Something From Their Bosses That Most Managers Struggle to Give

Elon Musk promised an AI epic to rival Christopher Nolan. Viewers got a seven-minute glitch

What Multiplier's talent trends reveal about the future of work

The Best and Worst Presidents for Inflation

General Motors to move stock listing from NYSE to Nasdaq in technology-focused shift